Diagnosis and management of subungual melanoma | RACGP ACCREDITED | 68 mins 1
Subungual melanoma is a rare form of melanoma that arises from the nail matrix. Diagnosis can be clinically and pathologically challenging which often results in delay that contributes to a poorer prognosis.
In this video presentation, our multidisciplinary experts discuss:
- How subungual melanoma differs from cutaneous melanoma
- The pitfalls in the pathological assessment of subungual biopsies and how these can be avoided
- Morphological differential diagnoses of longitudinal melanonychia, erythronychia and pachyonychia
- Biopsy and surgical management of subungual melanoma.
This video is suitable for Skin Cancer GPs, General GPs, Dermatologists, Surgeons and other healthcare professionals.
- Describe how subungual melanoma differs from cutaneous melanoma.
- Identify the pitfalls in the pathological assessment of subungual biopsies and how these can be avoided.
- Describe the morphological differential diagnoses of longitudinal melanonychia, erythronychia and pachyonychia.
- Outline the clinical and dermatoscopic features of nail matrix melanoma versus subungual haematoma.
- Summarise how to undertake a nailbed biopsy and complications that may arise.
- Describe the type of anaesthetic and technique to anaesthetise a digit in order to do a nail matrix biopsy.
This is an RACGP-approved CPD activity under the RACGP
CPD Program (Activity No. 401058).
A/Prof Linda Martin
Dermatologist, Melanoma Institute Australia | Professor in Dermatology, The University of NSW
Declaration of Interest
Dr David Stewart
Specialist Plastic and Reconstructive Surgeon, Sydney Orthopaedic and Reconstructive Specialist Centre, Royal North Shore Hospital and Children’s Hospital Westmead | Senior Lecturer, The University of Sydney
Dr Peter Ferguson
Pathologist, Melanoma Institute Australia and Royal Prince Alfred Hospital | Clinical Senior Lecturer, The University of Sydney
Declaration of Interest
Please note that this video was accurate at the time of recording (September 2023) but may not reflect the rapidly evolving treatment landscape and approvals in Australia.
MIA’s Education Program is proudly supported through unrestricted educational grants from:
[miniorange_social_login shape="longbuttonwithtext" theme="default" space="4" width="240" height="40"]
Module1.101 hour 08 min
Login with your site account
Register a new accountMelanoma Institute Australia uses website cookies to improve your browsing experience when using our website. ACCEPTREJECT